|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong IO, Schooling CM, Cowling BJ and
Leung GM: Breast cancer incidence and mortality in a transitioning
Chinese population: Current and future trends. Br J Cancer.
112:167–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jian W, Shao K, Qin Q and Wang X, Song S
and Wang X: Clinical and genetic characterization of hereditary
breast cancer in a Chinese population. Hered Cancer Clin Pract.
15:192017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liao Y, Li D, Zhang N, Xia C, Zheng R,
Zeng H, Zhang S, Wang J and Chen W: Application of sandwich spatial
estimation method in cancer mapping: A case study for breast cancer
mortality in the Chinese mainland, 2005. Stat Methods Med Res.
28:3609–3626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Z, Bao J, Yu C, Wang J and Li C:
Secular trends of breast cancer in China, South Korea, Japan and
the United States: Application of the age-period-cohort analysis.
Int J Environ Res Public Health. 12:15409–15418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Li J, Fan Y, Li X, Qiu J, Zhu M
and Li H: Risk factors for axillary lymph node metastases in
clinical stage T1-2N0M0 breast cancer patients. Medicine
(Baltimore). 98:e174812019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hennigs A, Riedel F, Feißt M, Köpke M,
Rezai M, Nitz U, Moderow M, Golatta M, Sohn C and Heil J: Evolution
of the use of completion axillary lymph node dissection in patients
with T1/2N0M0 breast cancer and tumour-involved sentinel lymph
nodes undergoing mastectomy: A cohort study. Ann Surg Oncol.
26:2435–2443. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taflampas P, Sanidas E, Christodoulakis M,
Askoxylakis J, Melissas J and Tsiftsis DD: Sealants after axillary
lymph node dissection for breast cancer: Good intentions but bad
results. Am J Surg. 198:55–58. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Madsen RJ, Esmonde NO, Ramsey KL and
Hansen JE: Axillary lymph node dissection is a risk factor for
major complications after immediate breast reconstruction. Ann
Plast Surg. 77:513–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Euscher E: Pathology of sentinel lymph
nodes: Historical perspective and current applications in
gynecologic cancer. Int J Gynecol Cancer. 30:394–401. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malter W, Hellmich M, Badian M, Kirn V,
Mallmann P and Krämer S: Factors predictive of sentinel lymph node
involvement in primary breast cancer. Anticancer Res. 38:3657–3662.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, He Y, Wang J, Huo L, Fan Z, Li J,
Xie Y, Wang T and Ouyang T: Feasibility of using negative
ultrasonography results of axillary lymph nodes to predict sentinel
lymph node metastasis in breast cancer patients. Cancer Med.
7:3066–3072. 2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu C, Ding J, Spuhler K, Gao Y, Serrano
Sosa M, Moriarty M, Hussain S, He X, Liang C and Huang C:
Preoperative prediction of sentinel lymph node metastasis in breast
cancer by radiomic signatures from dynamic contrast-enhanced MRI. J
Magn Reson Imaging. 49:131–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong Y, Feng Q, Yang W, Lu Z, Deng C,
Zhang L, Lian Z, Liu J, Luo X, Pei S, et al: Preoperative
prediction of sentinel lymph node metastasis in breast cancer based
on radiomics of T2-weighted fat-suppression and diffusion-weighted
MRI. Eur Radiol. 28:582–591. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Visser M, Jiwa M, Horstman A, Brink AA,
Pol RP, van Diest P, Snijders PJ and Meijer CJ: Intra-operative
rapid diagnostic method based on CK19 mRNA expression for the
detection of lymph node metastases in breast cancer. Int J Cancer.
122:2562–2567. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abe M, Kagara N, Miyake T, Tanei T, Naoi
Y, Shimoda M, Shimazu K, Kim SJ and Noguchi S: Highly sensitive
detection of sentinel lymph node metastasis of breast cancer by
digital PCR for RASSF1A methylation. Oncol Rep. 42:2382–2389.
2019.PubMed/NCBI
|
|
17
|
Gradishar WJ, Anderson BO, Abraham J, Aft
R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD,
et al: Breast cancer, version 3.2020, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 18:452–478. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buchtele N, Staudinger T, Schwameis M,
Schörgenhofer C, Herkner H and Hermann A; UltraECMO investigators,
: Feasibility and safety of watershed detection by
contrast-enhanced ultrasound in patients receiving peripheral
venoarterial extracorporeal membrane oxygenation: A prospective
observational study. Crit Care. 24:1262020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spiesecke P, Fischer T, Maxeiner A, Hamm B
and Lerchbaumer MH: Contrast-enhanced ultrasound (CEUS) reliably
rules out neoplasm in developmental renal pseudotumor. Acta Radiol.
62:821–829. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li C, Yao M, Shao S, Li X, Li G and Wu R:
Diagnostic efficacy of contrast-enhanced ultrasound for breast
lesions of different sizes: A comparative study with magnetic
resonance imaging. Br J Radiol. 93:201909322020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen C, Wang Y, Niu J, Liu X, Li Q and
Gong X: Domain knowledge powered deep learning for breast cancer
diagnosis based on contrast-enhanced ultrasound videos. IEEE Trans
Med Imaging. 40:2439–2451. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Li J, Qiao J, Guo X, Bian X, Guo
L, Liu Z and Lu Z: Establishment of a model for predicting sentinel
lymph node metastasis in early breast cancer based on
contrast-enhanced ultrasound and clinicopathological features.
Gland Surg. 10:1701–1712. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poodt IGM, Walstra CJEF, Vugts G,
Maaskant-Braat AJG, Voogd AC, Schipper RJ and Nieuwenhuijzen GAP;
Sentinel Node and Recurrent Breast Cancer (SNARB) study Group, :
Low risk of development of a regional recurrence after an
unsuccessful repeat sentinel lymph node biopsy in patients with
ipsilateral breast tumor recurrence. Ann Surg Oncol. 26:2417–2427.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oaks ZA, Goyal S, Liu Y, Hayes KR, Gupta
GP, Patel SA and Royce TJ: Sentinel lymph node biopsy (SLNB) versus
axillary lymph node dissection in US women with breast cancer and
persistently positive lymph nodes following neoadjuvant
chemotherapy. Int J Radiat Oncol Biol Phys. 108 (Suppl):e24–e25.
2020. View Article : Google Scholar
|
|
25
|
Qiu PF, Liu YB and Wang YS: Internal
mammary sentinel lymph node biopsy: Abandon or persist? Onco
Targets Ther. 9:3879–3882. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ugras S, Matsen C, Eaton A, Stempel M,
Morrow M and Cody HS III: Reoperative sentinel lymph node biopsy is
feasible for locally recurrent breast cancer, but is it worthwhile?
Ann Surg Oncol. 23:744–748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dasgupta P, Youl PH, Pyke C, Aitken JF and
Baade PD: Sentinel node biopsy for early breast cancer in
Queensland, Australia, during 2008–2012. ANZ J Surg. 88:E400–E405.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goonawardena J, Yong C and Law M: Use of
indocyanine green fluorescence compared to radioisotope for
sentinel lymph node biopsy in early-stage breast cancer: Systematic
review and meta-analysis. Am J Surg. 220:665–676. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meattini I, Desideri I, Saieva C,
Francolini G, Scotti V, Bonomo P, Greto D, Mangoni M, Nori J,
Orzalesi L, et al: Impact of sentinel node tumor burden on outcome
of invasive breast cancer patients. Eur J Surg Oncol. 40:1195–1202.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Caudle AS, Yi M, Hoffman KE, Mittendorf
EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA and Hunt KK:
Impact of identification of internal mammary sentinel lymph node
metastasis in breast cancer patients. Ann Surg Oncol. 21:60–65.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gkegkes ID and Lavazzo C: Contrast
enhanced ultrasound (CEU) using microbubbles for sentinel lymph
node biopsy in breast cancer: A systematic review. Acta Chir Belg.
115:212–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao J, Zhang J, Zhu QL, Jiang YX, Sun Q,
Zhou YD, Wang MQ, Meng ZL and Mao XX: The value of
contrast-enhanced ultrasound for sentinel lymph node identification
and characterisation in pre-operative breast cancer patients: A
prospective study. Eur Radiol. 28:1654–1661. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie F, Zhang D, Cheng L, Yu L, Yang L,
Tong F, Liu H and Wang S and Wang S: Intradermal microbubbles and
contrast-enhanced ultrasound (CEUS) is a feasible approach for
sentinel lymph node identification in early-stage breast cancer.
World J Surg Oncol. 13:3192015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cook NR: Use and misuse of the receiver
operating characteristic curve in risk prediction. Circulation.
115:928–935. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hajian-Tilaki K: Receiver operating
characteristic (ROC) curve analysis for medical diagnostic test
evaluation. Caspian J Intern Med. 4:627–635. 2013.PubMed/NCBI
|
|
36
|
Iasonos A, Schrag D, Raj GV and Panageas
KS: How to build and interpret a nomogram for cancer prognosis. J
Clin Oncol. 26:1364–1370. 2008. View Article : Google Scholar : PubMed/NCBI
|
